Immune Therapeutics, Inc. , a clinical-stage company developing novel therapies for the treatment of immuno-inflammatory diseases and cancer, today announced that it will hold a special investor conference call to discuss the Company’s recent operating highlights and its financial and operational outlook for 2017.  The conference call will follow a press release that will be issued pre-market on January 30, 2017 summarizing these topics. / EIN News / — Please call in 10 minutes prior to the conference call to assure you are placed into the call on time.